Ovarian Cancer: PARP Inhibitor Eligibility

Written by: Martina Fraga, PharmD Download Here Description: The purpose of this PQI is to highlight effective practices to ensure ovarian cancer patients are identified, tested, tracked, and offered a PARP inhibitor when appropriate. Background: In gynecologic cancer...